Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention

Background: Patients with a high risk of bleeding undergoing percutaneous coronary intervention (PCI-HBR) were provided consensus-based criteria by the Academic Research Consortium for High Bleeding Risk (ARC-HBR). However, the prognostic predictors in this group of patients have...

Full description

Saved in:
Bibliographic Details
Main Authors: Junyan Zhang, Zhongxiu Chen, Ran Liu, Yuxiao Li, Hongsen Zhao, Yanning Li, Minggang Zhou, Hua Wang, Chen Li, Li Rao, Yong He
Format: Article
Language:English
Published: IMR Press 2025-01-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25352
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586507956781056
author Junyan Zhang
Zhongxiu Chen
Ran Liu
Yuxiao Li
Hongsen Zhao
Yanning Li
Minggang Zhou
Hua Wang
Chen Li
Li Rao
Yong He
author_facet Junyan Zhang
Zhongxiu Chen
Ran Liu
Yuxiao Li
Hongsen Zhao
Yanning Li
Minggang Zhou
Hua Wang
Chen Li
Li Rao
Yong He
author_sort Junyan Zhang
collection DOAJ
description Background: Patients with a high risk of bleeding undergoing percutaneous coronary intervention (PCI-HBR) were provided consensus-based criteria by the Academic Research Consortium for High Bleeding Risk (ARC-HBR). However, the prognostic predictors in this group of patients have yet to be fully explored. Thus, an effective prognostic prediction model for PCI-HBR patients is required. Methods: We prospectively enrolled PCI-HBR patients from May 2022 to April 2024 at West China Hospital of Sichuan University. The cohort was randomly divided into training and internal validation sets in a ratio of 7:3. The least absolute shrinkage and selection operator (LASSO) regression algorithm was employed to select variables in the training set. Subsequently, a prediction model for 1-year net adverse clinical events (NACEs)-free survival was developed using a multivariable Cox regression model, and a nomogram was constructed. The outcome of the NACEs is defined as a composite endpoint that includes death, myocardial infarction, ischemic stroke, and Bleeding Academic Research Consortium (BARC) grade 3–5 major bleeding. Validation was conducted exclusively using the internal validation cohort, assessing the discrimination, calibration, and clinical utility of the nomogram. Results: This study included 1512 patients with PCI-HBR, including 1058 in the derivation cohort and 454 in the validation cohort. We revealed five risk factors after LASSO regression, Cox regression, and clinical significance screening. These were then utilized to construct a prognostic prediction nomogram, including chronic kidney disease, left main stem lesion, multivessel disease, triglycerides (TG), and creatine kinase-myocardial band (CK-MB). The nomogram exhibited strong predictive ability (the area under the curve (AUC) to predict 1-year NACE-free survival was 0.728), displaying favorable levels of accuracy, discrimination, and clinical usefulness in the internal validation cohort. Conclusions: This study presents a nomogram to predict 1-year NACE outcomes in PCI-HBR patients. Internal validation showed strong predictive capability and clinical utility. Future research should validate the nomogram in diverse populations and explore new predictors for improved accuracy. Clinical Trial Registration: The data for this study were obtained from the PPP-PCI registry, NCT05369442 (https://clinicaltrials.gov/study/NCT05369442).
format Article
id doaj-art-5ad12655a7be4ee38b58c91c12b86396
institution Kabale University
issn 1530-6550
language English
publishDate 2025-01-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj-art-5ad12655a7be4ee38b58c91c12b863962025-01-25T10:41:20ZengIMR PressReviews in Cardiovascular Medicine1530-65502025-01-012612535210.31083/RCM25352S1530-6550(24)01635-1Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary InterventionJunyan Zhang0Zhongxiu Chen1Ran Liu2Yuxiao Li3Hongsen Zhao4Yanning Li5Minggang Zhou6Hua Wang7Chen Li8Li Rao9Yong He10Department of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaInformation Center of West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaInformation Center of West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaInformation Center of West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, 610041 Chengdu, Sichuan, ChinaBackground: Patients with a high risk of bleeding undergoing percutaneous coronary intervention (PCI-HBR) were provided consensus-based criteria by the Academic Research Consortium for High Bleeding Risk (ARC-HBR). However, the prognostic predictors in this group of patients have yet to be fully explored. Thus, an effective prognostic prediction model for PCI-HBR patients is required. Methods: We prospectively enrolled PCI-HBR patients from May 2022 to April 2024 at West China Hospital of Sichuan University. The cohort was randomly divided into training and internal validation sets in a ratio of 7:3. The least absolute shrinkage and selection operator (LASSO) regression algorithm was employed to select variables in the training set. Subsequently, a prediction model for 1-year net adverse clinical events (NACEs)-free survival was developed using a multivariable Cox regression model, and a nomogram was constructed. The outcome of the NACEs is defined as a composite endpoint that includes death, myocardial infarction, ischemic stroke, and Bleeding Academic Research Consortium (BARC) grade 3–5 major bleeding. Validation was conducted exclusively using the internal validation cohort, assessing the discrimination, calibration, and clinical utility of the nomogram. Results: This study included 1512 patients with PCI-HBR, including 1058 in the derivation cohort and 454 in the validation cohort. We revealed five risk factors after LASSO regression, Cox regression, and clinical significance screening. These were then utilized to construct a prognostic prediction nomogram, including chronic kidney disease, left main stem lesion, multivessel disease, triglycerides (TG), and creatine kinase-myocardial band (CK-MB). The nomogram exhibited strong predictive ability (the area under the curve (AUC) to predict 1-year NACE-free survival was 0.728), displaying favorable levels of accuracy, discrimination, and clinical usefulness in the internal validation cohort. Conclusions: This study presents a nomogram to predict 1-year NACE outcomes in PCI-HBR patients. Internal validation showed strong predictive capability and clinical utility. Future research should validate the nomogram in diverse populations and explore new predictors for improved accuracy. Clinical Trial Registration: The data for this study were obtained from the PPP-PCI registry, NCT05369442 (https://clinicaltrials.gov/study/NCT05369442).https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25352percutaneous coronary interventionhigh bleeding risknomogramprognosisprediction modelinternal validation
spellingShingle Junyan Zhang
Zhongxiu Chen
Ran Liu
Yuxiao Li
Hongsen Zhao
Yanning Li
Minggang Zhou
Hua Wang
Chen Li
Li Rao
Yong He
Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
Reviews in Cardiovascular Medicine
percutaneous coronary intervention
high bleeding risk
nomogram
prognosis
prediction model
internal validation
title Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
title_full Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
title_fullStr Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
title_full_unstemmed Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
title_short Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
title_sort development and validation of a nomogram for predicting long term net adverse clinical events in high bleeding risk patients undergoing percutaneous coronary intervention
topic percutaneous coronary intervention
high bleeding risk
nomogram
prognosis
prediction model
internal validation
url https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25352
work_keys_str_mv AT junyanzhang developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT zhongxiuchen developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT ranliu developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT yuxiaoli developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT hongsenzhao developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT yanningli developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT minggangzhou developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT huawang developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT chenli developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT lirao developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention
AT yonghe developmentandvalidationofanomogramforpredictinglongtermnetadverseclinicaleventsinhighbleedingriskpatientsundergoingpercutaneouscoronaryintervention